ALERT: Lysol: Monkeypox Information. To help answer your Monkeypox questions, we've created a one stop FAQ resource.

[Mary Wilson]

Cases of monkeypox are being investigated in the United States. Lysol is continuing to work with a wide range of scientific and health experts to educate the public on the importance of hygiene as the global community continues to fight the COVID-19 pandemic and emergence of monkeypox. Lysol understands that hygiene is the foundation of health, because it breaks the chain of infection of many transmissible diseases.

On May 23 2022, EPA invoked the viral emerging pathogen protocol in regard to monkeypox. Specific Lysol products have demonstrated effectiveness against viruses similar to monkeypox on hard, non-porous surfaces. In accordance with the EPA Viral Emerging Pathogen Policy, the following Lysol products can be used against monkeypox, when used in accordance with the directions for use. ...

https://www.lysol.com/clean-and-protect/protect-against-germs/other-illnesses/monkeypox-faq

 

[Mary Wilson]

An official website of the United States government
EPA

Emerging Viral Pathogen Guidance and Status for Antimicrobial Pesticides

Overview

The National Institute of Allergy and Infectious Diseases defines “emerging infectious diseases/pathogens”EXITEXIT EPA WEBSITE as those “that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range.”

Many of the emerging pathogens of greatest concern are pathogenic viruses. How long these viruses last on surfaces can play a role in the disease transmission.

Because the occurrence of emerging viral pathogens (EVPs) is less common and less predictable than established pathogens, few if any EPA-registered disinfectant product labels specify use against this category of infectious agents. Therefore, in 2016, EPA provided a voluntary, two-stage process to enable use of certain EPA-registered disinfectant products against emerging viral pathogens not identified on the product label.

A company can apply for an emerging viral pathogen claim, even before an outbreak occurs, based on previous EPA-approved claims for specific hard-to-kill viruses.

EPA reviews the supporting information and determines if the claim is acceptable. Once approved, a company can make certain off-label claims as specified in that guidance in the event of an outbreak. For instance, the preapproved company can include certain statements about expected efficacy on:

• technical literature distributed to health care facilities, physicians, nurses, and public health officials;
• non-label-related websites;
• consumer information services; and
• social media sites.

Active Cases Triggering the Emerging Viral Pathogens Policy

The Emerging Viral Pathogens guidance is currently active for the following pathogens:

Monkeypox virus	Monkeypox is a rare disease that is caused by infection with monkeypox virus. Learn more about monkeypox in the United States.EXITEXIT EPA WEBSITE	May, 2022	May, 2023	List Q: Disinfectants for Emerging Viral Pathogens (EVPs)

https://www.epa.gov/pesticide-regis...-guidance-and-status-antimicrobial-pesticides